Tandem Diabetes Care, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Tandem Diabetes Care, Inc. (TNDM) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $225.81 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $225.81M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $205.35M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $118.33M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $119.86M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2026-06-30 | $225.81M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $205.35M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $118.33M 10-K · filed 2026-02-19 |
| 2025-09-30 | $119.86M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $112.02M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $170.72M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $213.90M 10-K · filed 2025-02-26 |
| 2024-09-30 | $218.03M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $219.67M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $212.17M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $246.22M 10-K · filed 2024-02-21 |
| 2023-09-30 | $326.59M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $317.97M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $335.41M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $404.44M 10-K · filed 2023-02-22 |
| 2022-09-30 | $457.24M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $485.60M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $450.87M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $417.73M 10-K · filed 2022-02-22 |
| 2021-09-30 | $399.33M 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |